CONMED Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.4 | $1.3 | $1.2 | $1.0 | $1.0 |
| Operating income | $0.1 | $0.2 | $0.1 | $0.1 | $0.1 |
| Net income | $<0.1 | $0.1 | $0.1 | -$0.1 | $0.1 |
| Cash Flow Statement | |||||
| Free cash flow | $0.2 | $0.2 | $0.1 | $<0.1 | $0.1 |
| Dividends | $<0.1 | $<0.1 | $<0.1 | $<0.1 | $<0.1 |
Shares outstanding 30.0M · Free float 99.2%
Annual filing data through FY ended December 31, 2025; float as of September 21, 2026.